Success Metrics

Clinical Success Rate
87.5%

Based on 14 completed trials

Completion Rate
88%(14/16)
Active Trials
0(0%)
Results Posted
57%(8 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_4
6
35%
Ph not_applicable
2
12%
Ph phase_2
6
35%
Ph phase_3
2
12%
Ph phase_1
1
6%

Phase Distribution

1

Early Stage

6

Mid Stage

8

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
6(35.3%)
Phase 3Large-scale testing
2(11.8%)
Phase 4Post-market surveillance
6(35.3%)
N/ANon-phased studies
2(11.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

14 of 16 finished

Non-Completion Rate

12.5%

2 ended early

Currently Active

0

trials recruiting

Total Trials

17

all time

Status Distribution
Completed(14)
Terminated(2)
Other(1)

Detailed Status

Completed14
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.9%)
Phase 26 (35.3%)
Phase 32 (11.8%)
Phase 46 (35.3%)
N/A2 (11.8%)

Trials by Status

terminated212%
unknown16%
completed1482%

Recent Activity

0 active trials
Showing 5 of 17
completednot_applicable

Bupropion in the Treatment of Methamphetamine Dependence

NCT00572234
completedphase_2

AXS-05 Phase II Trial on Smoking Behavior

NCT03471767
unknownphase_2

An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients

NCT04971291
completedphase_4

A Comparison of Bupropion SR and Placebo for Smoking Cessation

NCT00176449
completedphase_4

Bupropion for Smoking Cessation During Pregnancy

NCT01390246
View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT00572234Not Applicable

Bupropion in the Treatment of Methamphetamine Dependence

Completed
NCT03471767Phase 2

AXS-05 Phase II Trial on Smoking Behavior

Completed
NCT04971291Phase 2

An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients

Unknown
NCT00176449Phase 4

A Comparison of Bupropion SR and Placebo for Smoking Cessation

Completed
NCT01390246Phase 4

Bupropion for Smoking Cessation During Pregnancy

Completed
NCT00330187Phase 2

Combined Pharmaco/Behavior Therapy in Adolescent Smokers

Completed
NCT00307203Phase 4

Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke

Completed
NCT01286402Phase 2

Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy

Completed
NCT01048944Phase 4

Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers

Completed
NCT00935818Phase 2

Varenicline and Bupropion for Smoking Cessation

Completed
NCT01875172Phase 2

Bupropion for Smoking Cessation in Pregnancy

Completed
NCT01270555Not Applicable

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Completed
NCT00133757Phase 1

Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers

Completed
NCT00181896Phase 4

Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder

Terminated
NCT00119210Phase 4

Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women

Terminated
NCT00414180Phase 3

Bupropion SR for Treating Smokeless Tobacco Use

Completed
NCT00344695Phase 3

Bupropion Treatment for Youth Smoking Cessation

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17